Occudo Quantitative Strategies LP Invests $356,000 in Genesco Inc. (NYSE:GCO)

Occudo Quantitative Strategies LP bought a new position in Genesco Inc. (NYSE:GCO) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 8,333 shares of the company’s stock, valued at approximately $356,000. Occudo Quantitative Strategies LP owned about 0.07% of Genesco as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of GCO. SG Americas Securities LLC bought a new stake in shares of Genesco during the 4th quarter valued at about $111,000. Bayesian Capital Management LP bought a new stake in shares of Genesco during the 4th quarter valued at about $234,000. Wells Fargo & Company MN grew its position in shares of Genesco by 28.1% during the 4th quarter. Wells Fargo & Company MN now owns 5,846 shares of the company’s stock valued at $250,000 after buying an additional 1,281 shares during the last quarter. Inceptionr LLC bought a new stake in shares of Genesco during the 4th quarter valued at about $264,000. Finally, Corton Capital Inc. bought a new stake in shares of Genesco during the 4th quarter valued at about $299,000. Institutional investors own 94.51% of the company’s stock.

Insider Buying and Selling at Genesco

In other news, major shareholder Fund 1 Investments, Llc sold 12,000 shares of the company’s stock in a transaction that occurred on Friday, March 28th. The shares were sold at an average price of $20.73, for a total value of $248,760.00. Following the completion of the sale, the insider now directly owns 1,097,850 shares of the company’s stock, valued at approximately $22,758,430.50. This represents a 1.08% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Gregory A. Sandfort purchased 10,974 shares of Genesco stock in a transaction dated Thursday, March 20th. The stock was bought at an average cost of $22.92 per share, with a total value of $251,524.08. Following the completion of the purchase, the director now owns 26,754 shares in the company, valued at approximately $613,201.68. This trade represents a 69.54% increase in their position. The disclosure for this purchase can be found here. 7.09% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded shares of Genesco from a “buy” rating to a “hold” rating in a research report on Tuesday, April 15th.

Genesco Price Performance

Shares of NYSE:GCO opened at $24.04 on Friday. The company has a quick ratio of 0.32, a current ratio of 1.56 and a debt-to-equity ratio of 0.19. Genesco Inc. has a fifty-two week low of $16.19 and a fifty-two week high of $44.80. The firm has a 50-day simple moving average of $20.52 and a 200 day simple moving average of $31.56. The company has a market cap of $265.35 million, a PE ratio of -9.89 and a beta of 2.14.

Genesco (NYSE:GCO) last posted its earnings results on Friday, March 7th. The company reported $3.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.31 by ($0.05). The firm had revenue of $745.95 million for the quarter, compared to analyst estimates of $780.43 million. Genesco had a negative net margin of 1.13% and a positive return on equity of 0.56%. During the same period in the previous year, the firm earned $2.59 earnings per share. On average, sell-side analysts anticipate that Genesco Inc. will post 0.94 EPS for the current year.

Genesco Profile

Genesco Inc operates as a retailer and wholesaler of footwear, apparel, and accessories in the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands.